美国 · SEC FORM 4
BIO-TECHNE Corp
TECH · Nasdaq · CIK 0000842023 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
38 同一窗口内观察到的 Form 4 交易行
1 sales · 37 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-05-10 · BAUMGARTNER ROBERT V.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,385,034
- 上期报告
- 6,627,623
- 日均成交量
- 3,556,189
- 回补天数
- 2.1
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-05-10 | BAUMGARTNER ROBERT V | 买入 (P) | Common Stock | 300 | USD 352.55 | USD 105,765 | SEC 申报 ↗ |
Form 4 申报证据
61 transaction lines in the latest 365-day window; 497 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | HIGGINS JOHN L | 期权行权／转换 (M) | Common Stock | 15,940 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-28 | HIGGINS JOHN L | 代扣税 (F) | Common Stock | 5,562 | USD 72.51 | USD 403,301 | SEC 申报 ↗ |
| 2026-09-22 | BAUMGARTNER ROBERT V | 期权行权／转换 (M) | Common Stock | 15,940 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | HIGGINS JOHN L | 期权行权／转换 (M) | Common Stock | 15,940 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-28 | HIGGINS JOHN L | 代扣税 (F) | Common Stock | 5,562 | USD 72.51 | USD 403,301 | SEC 申报 ↗ |
| 2026-09-22 | BAUMGARTNER ROBERT V | 期权行权／转换 (M) | Common Stock | 15,940 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-22 | BAUMGARTNER ROBERT V | 代扣税 (F) | Common Stock | 5,559 | USD 72.55 | USD 403,305 | SEC 申报 ↗ |
| 2026-08-15 | Kelderman Kim | 期权行权／转换 (M) | Common Stock | 21,470 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Kelderman Kim | 代扣税 (F) | Common Stock | 10,821 | USD 72.40 | USD 783,440 | SEC 申报 ↗ |
| 2026-08-15 | Hippel James | 期权行权／转换 (M) | Common Stock | 9,779 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Hippel James | 代扣税 (F) | Common Stock | 4,310 | USD 72.40 | USD 312,044 | SEC 申报 ↗ |
| 2026-08-15 | Herr Amy E. | 期权行权／转换 (M) | Common Stock | 589 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Herr Amy E. | 代扣税 (F) | Common Stock | 213 | USD 72.40 | USD 15,421 | SEC 申报 ↗ |
| 2026-08-15 | Geist William | 期权行权／转换 (M) | Common Stock | 6,416 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Geist William | 代扣税 (F) | Common Stock | 1,976 | USD 72.40 | USD 143,062 | SEC 申报 ↗ |
| 2026-08-15 | Crouse Steven C. | 期权行权／转换 (M) | Common Stock | 5,423 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Crouse Steven C. | 代扣税 (F) | Common Stock | 1,947 | USD 72.40 | USD 140,963 | SEC 申报 ↗ |
| 2026-08-15 | Bohnen Shane | 期权行权／转换 (M) | Common Stock | 4,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-15 | Bohnen Shane | 代扣税 (F) | Common Stock | 1,343 | USD 72.40 | USD 97,233 | SEC 申报 ↗ |
| 2026-07-29 | Hippel James | 期权行权／转换 (M) | Common Stock | 62,068 | USD 47.60 | USD 2,954,437 | SEC 申报 ↗ |
| 2026-07-29 | Hippel James | 代扣税 (F) | Common Stock | 51,024 | USD 72.03 | USD 3,675,259 | SEC 申报 ↗ |
| 2026-07-28 | Kelderman Kim | 期权行权／转换 (M) | Common Stock | 35,000 | USD 47.60 | USD 1,666,000 | SEC 申报 ↗ |
| 2026-07-28 | Kelderman Kim | 代扣税 (F) | Common Stock | 28,686 | USD 72.07 | USD 2,067,400 | SEC 申报 ↗ |
| 2026-07-23 | Bohnen Shane | 期权行权／转换 (M) | Common Stock | 448 | USD 47.60 | USD 21,325 | SEC 申报 ↗ |
| 2026-07-23 | Bohnen Shane | 代扣税 (F) | Common Stock | 344 | USD 71.77 | USD 24,689 | SEC 申报 ↗ |
| 2026-06-02 | Crouse Steven C. | 期权行权／转换 (M) | Common Stock | 600 | USD — | USD — | SEC 申报 ↗ |
| 2026-06-02 | Crouse Steven C. | 代扣税 (F) | Common Stock | 216 | USD 49.77 | USD 10,750 | SEC 申报 ↗ |
| 2026-05-08 | Herr Amy E. | 卖出 (S) | Common Stock | 6,636 | USD 48.28 | USD 320,386 | SEC 申报 ↗ |
| 2026-05-08 | Herr Amy E. | 期权行权／转换 (M) | Common Stock | 6,636 | USD 47.60 | USD 315,874 | SEC 申报 ↗ |
| 2026-05-05 | Kelderman Kim | 期权行权／转换 (M) | Common Stock | 26,692 | USD 47.60 | USD 1,270,539 | SEC 申报 ↗ |
| 2026-05-05 | Kelderman Kim | 代扣税 (F) | Common Stock | 23,951 | USD 56.68 | USD 1,357,543 | SEC 申报 ↗ |
| 2026-05-05 | Hippel James | 期权行权／转换 (M) | Common Stock | 62,000 | USD 47.60 | USD 2,951,200 | SEC 申报 ↗ |
| 2026-05-05 | Hippel James | 代扣税 (F) | Common Stock | 56,955 | USD 56.68 | USD 3,228,209 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | TECH |
| CIK | 0000842023 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 497 transaction lines from 2020-01-02 to 2026-09-28 1 P purchase lines · 203 S sale lines · 293 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.